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OBJECTIVE — To examine trends in the prevalence of diabetes among delivery hospitaliza-
tions in the U.S. and to describe the characteristics of these hospitalizations.
RESEARCH DESIGN AND METHODS — Hospital discharge data from 1994 through
2004 were obtained from the Nationwide Inpatient Sample. Diagnosis codes were selected for
gestational diabetes mellitus (GDM), type 1 diabetes, type 2 diabetes, and unspeciﬁed diabetes.
Rates of delivery hospitalization with diabetes were calculated per 100 deliveries.
RESULTS — Overall, an estimated 1,863,746 hospital delivery discharges contained a diabe-




each age-group (15–24, 25–34, and 35 years) (P  0.05). The largest percent increase for all
ages was among type 2 diabetes (367%). By age-group, the greatest percent increases for each
diabetes type were among the two younger groups. Signiﬁcant predictors of diabetes at delivery
included age 35 years vs. 15–24 years (odds ratio 4.80 [95% CI 4.72–4.89]), urban versus




population and target strategies to minimize risk for maternal/fetal complications.
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D
iabetesisthemostfrequentmetabolic
complication of pregnancy and is as-
sociatedwithanincreasedriskofma-




although most commonly reported ﬁgures
range from 2 to 5% (3,4). With the rapid
rise of type 2 diabetes among women in
general, it is expected that this condition
will also affect pregnant women at an in-
creasing rate.
Anumberofstudieshavereportedin-
creasing trends for pregestational diabe-
tes, GDM, or both (5–7). The majority of
these results, however, generally describe
diabetes patterns at more localized levels
in the U.S. Studies that have assessed di-
abetes trends in pregnancy at the national
level have done so with a speciﬁc focus
only on GDM, reporting marked in-
creases in prevalence over the past 2 de-
cades (8,9).
As a comparison to these previously
reported numbers and for a more com-
prehensive assessment of diabetes in
pregnancy in the U.S., the purpose of this
analysis was to examine trends and char-
acteristics of delivery hospitalizations
with a recorded diabetes diagnosis of
GDM,type1diabetes,andtype2diabetes
between1994and2004usingtheHealth-
care Cost and Utilization Project (HCUP)
Nationwide Inpatient Sample (NIS), a na-
tionally representative sample of inpa-
tient care. Given the rising background
rates of type 2 diabetes, together with in-
creases in risk factors for diabetes, which
may be contributing to the trends in the
general population, we expected that
trends among pregnant women, particu-
larly for GDM and type 2 diabetes, would
also steadily increase, reﬂecting the pat-
terns reported in localized studies.
RESEARCH DESIGN AND
METHODS— We obtained data from
the NIS, one of a family of research data-
bases developed as part of the HCUP. It is
sponsored by the Agency for Healthcare
Research and Quality in partnership with
public and private statewide data organi-
zations to provide national estimates of
inpatient care delivered in the U.S. (10).
During annual data collection by HCUP,
all community hospitals from participat-
ing states are stratiﬁed by rural/urban lo-
cation, number of beds, geographic
region, teaching status, and ownership.
Within each stratum, a systematic ran-
dom 20% sample of hospitals (1,000
hospitals) is drawn (11). The NIS in-
cludes all discharges from the sampled
hospitals and can be used to produce na-
tionwide estimates of inpatient care. It is
thelargestcollectionofall-payerinpatient
care data in the U.S. and provides patient
demographic and diagnostic/procedural
data as well as facility information.
Our analysis was conducted using
NIS data from 1994 through 2004. Hos-
pital discharge diagnoses were identiﬁed
usingtheICD-9-CMcodesanddiagnosis-
related group (DRG) codes. The unit of
analysis was the hospitalization of a fe-
male patient aged15 years that resulted
in a delivery as identiﬁed by a discharge
ICD-9-CMcodeofV27.0–V27.9and/ora
DRGcodeof370–375listedanywhereon
the discharge record. We identiﬁed hos-
pitalizations with a diabetes diagnosis
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ICD-9-CM codes for diabetes listed any-
where on the discharge record. GDM was
identiﬁedbyICD-9-CMcode648.8Xand
type 1 and type 2 diabetes were identiﬁed
by the appropriate 250.XX codes. Un-
speciﬁed diabetes codes were deﬁned as
those that do not indicate type (790.29,
648.0–648.04, and 250–250.9). Where
records were coded with two or more dif-
ferent diabetes code types, we con-
structedthefollowinghierarchicalcoding
scheme: if a type 1 code appeared along-
side any other code(s) for diabetes, the
type 1 code would supersede all others,
and the discharge record would be cate-
gorized as type 1 diabetes. If any of the
speciﬁc diabetes types were listed along-
side an unspeciﬁed code, the more spe-
ciﬁc diabetes code type would supersede.
If GDM and type 2 were listed together,
thatrecordwouldbecategorizedastype2
diabetes. Discharge records with only un-
speciﬁed diabetes codes were only in-
cludedinanalysesexaminingalldiabetes.
All results were weighted estimates
representing the total number of delivery
hospitalizations from 1994 to 2004 in the
U.S. Overall and age-speciﬁc rates of hos-
pitalizations with any diabetes and by
type were calculated per 100 deliveries.
Because the sampling frame for the NIS
changed over time, an alternate set of NIS
discharge and hospital weights were used
forthe1994–1997dataset.Theseweights
werecalculatedbyHCUPinthesameway
as the weights for 1998 and later years of
the NIS (12).
Demographic and hospital character-
istics examined included maternal age,
intended payer (Medicaid/Medicare, pri-
vate insurance, and other types of pay-
ment), hospital location (rural/urban),
geographic region (Northeast, Midwest,
South, or West), mode of delivery (cesar-
ean/vaginal), length of stay, hospital
charges, and number of procedures and
diagnoses. Because race is not uniformly
collected by all states, we elected not to
examine this variable because of the po-
tential for systematic bias. ANOVA or 
2
and t tests were used to compare all cate-
gorical and continuous demographic and
hospital variables between hospitaliza-
tions with any diabetes and no diabetes,
and among each of the three diabetes
typesandthenodiabeticgroup.P0.05
was considered signiﬁcant. All charges
were adjusted for inﬂation to 2004 dollar
levels using the Consumer Price Index
(13). Multivariate logistic regression was
used to estimate odds ratios (ORs) and
95% CI of having an ICD-9-CM code for
any diabetes and for each diabetes type in
2004 compared with that in 1994, as well
asbyage,urban/rurallocation,payer,and
region. All analyses were conducted with
SUDAAN (version 9; Research Triangle
Institute,ResearchTrianglePark,NC)us-
ingsurveymethodsthatappropriatelyad-
just for sampling weights. Because the
NIS is a publicly available database that
uses de-identiﬁed information, this anal-
ysis was exempt from internal review
board approval.
RESULTS— Using delivery-related
ICD-9-CM and DRG codes, there were
8,724,814 delivery hospitalization dis-
charges available for analysis, 379,461 of
which had a code for diabetes. Applying
survey methods to adjust for sampling
weights, there were an estimated
1,863,746 records with diabetes among
43,121,708 delivery discharges: an over-
allrateof4.3dischargeswithdiabetesper
100 deliveries in the U.S. from 1994 to
2004.AmongthosewithacodeforGDM,
the rate over this time period was 3.7 per
100 deliveries. Discharge records with a
code for GDM accounted for the largest
proportion of all delivery hospitalizations
with diabetes (84.7%), followed by those
with type 1 (7%), type 2 (4.7%), and un-
speciﬁed (3.6%) diabetes.
Trendsinalldiabetestypescombined
and in each of the speciﬁc types among
delivery hospitalizations are presented in
Fig. 1. All types signiﬁcantly increased
Figure 1—Trends for all diabetes (E), GDM (‚), type 1 diabetes (f), and type 2 diabetes (F) among delivery hospitalizations in the U.S.,
1994–2004.
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change over time for each diabetes type
arepresentedinTable1byage-groupand
for three selected years (ﬁrst, midpoint,
and last). The rates for all diabetes as well
as for GDM, type 1 diabetes, and type 2
diabetes signiﬁcantly increased in all of
the three age-groups throughout the
length of the study period. The largest
percent increase overall occurred among
those deliveries coded with type 2 diabe-
tes (367%); the lowest percent increase
was observed among those coded with
type 1 diabetes (33%). The highest rates
ofdiabetesoverallandbytypeforallyears
combined were found among those aged
35 years. When percent change from
1994 to 2004 was examined, however,
the greatest increases were observed
among the younger age-groups (25–34
years and 15–24 years) for all three
subtypes.
Demographic and hospital character-
istics of delivery hospitalizations by dia-
betes type are presented in Table 2.
Delivery hospitalizations with any diabe-
tes versus no diabetes comprised individ-
uals who were older, delivered in an
urban versus rural hospital, and had a ce-
sareandelivery.Hospitalizationswithany
diabetes also had a greater number of di-
agnoses on record, longer lengths of stay,
and higher hospital charges, even after
stratiﬁcation by mode of delivery. In a
comparison by diabetes type, those with
type 2 diabetes were the oldest, had the
highest frequency of delivery in an urban
hospital,andhadthehighestfrequencyof
Medicaid/Medicare as the primary payer.
The highest proportions of cesarean de-
liveries were observed among the groups
with type 1 diabetes, followed by type 2
diabetes. The type 1 deliveries also had
the longest lengths of stay and the highest
total hospital charges, even after stratiﬁ-
cation by mode of delivery.
Table 3 presents the adjusted odds of
a diabetes diagnosis among the delivery
hospitalizations. Delivery hospitaliza-
tions in 2004 were 1.5 times more likely
tohaveadiabetes-relatedICD-9-CMcode
compared with those in 1994 even after
adjustment for age, location, payer, and
geographic region. Other signiﬁcant pre-
dictors of having a diabetes code at deliv-
ery included age 35 years vs. 15–24
years (OR 4.80 [95% CI 4.72–4.89]), ur-
ban versus rural location (1.14 [1.11–
1.17]), Medicaid/Medicare versus other
paymentsources(1.29[1.26–1.32]),and
southern geographic region (1.10 [1.06–
1.14]). The same predictors also re-
mained signiﬁcant for each diabetes type.
CONCLUSIONS — The most com-
mon national ﬁgures reported for GDM
lie between 2 and 5%, whereas pregesta-
tional diabetes is said to affect 1% of all
pregnancies (2,4). Other population-
based investigations have also found in-
creasing trends in GDM, consistent with
our own ﬁndings (5,6,8,9). With respect
to trends for type 1 and type 2 diabetes
among pregnant women, no other stud-
ies, to our knowledge, have documented
nationaltrendsinpregestationaldiabetes,
which we observed to increase through-
out the length of the study period.
As expected, we found that older ma-
ternal age was an independent predictor
of any diabetes among delivery hospital-
izations. This association likely contrib-
uted to the observed increase in the
overall rate of diabetes as the proportion
of U.S. births to older women also in-
creased (14). Nonetheless, we found that
diabetesratesamongdeliveryhospitaliza-
tions increased for all ages, most sharply
among the younger age-groups, noted for
all three diabetes types. Other studies
Table 1—Yearly and overall rates of delivery hospitalizations with diabetes in the U.S. by type, 1994–2004
n* Overall rate† 1994 1999 2004 % change‡
All diabetes
Age (years)
15–24 317,457 2.06 1.72 1.93 2.50 45.3
25–34 1,058,087 4.84 3.91 4.61 6.08 55.5
35 488,203 8.37 7.03 7.71 10.29 46.4
All ages (crude) 1,863,746 4.32 3.49 4.04 5.47 56.3
GDM
Age (years)
15–24 257,255 1.67 1.37 1.54 2.02 47.4
25–34 901,570 4.12 3.34 3.93 5.16 54.5
35 419,879 7.20 6.06 6.70 8.79 45.0
All ages (crude) 1,578,703 3.66 2.95 3.42 4.61 56.2
Type 1 diabetes
Age (years)
15–24 32,813 0.21 0.17 0.23 0.24 42.4
25–34 71,570 0.33 0.27 0.34 0.35 28.1
35 25,917 0.44 0.36 0.41 0.45 24.2
All ages (crude) 130,300 0.30 0.24 0.31 0.33 33.2
Type 2 diabetes
Age (years)
15–24 14,026 0.09 0.05 0.07 0.18 260.0
25–34 48,248 0.22 0.09 0.18 0.45 388.0
35 25,203 0.43 0.24 0.34 0.84 250.0
All ages (crude) 87,477 0.20 0.09 0.16 0.42 366.7
Data are expressed as rates per 100 deliveries. P values for all trends from 1994 to 2004 were signiﬁcant at P  0.05. *n represents estimated number of delivery
hospitalizations with a diabetes diagnosis. †Indicates overall rate from 1994 through 2004. ‡Indicates rate change from 1994 to 2004.
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lighting concerns about the rise of diabe-
tes among younger women, a group
previously thought to be at lower risk
(7,8). Additional factors that may be con-
tributing to increases include improve-
ments in screening and detection, as well
as the rising prevalence of diabetes risk
factors, such as obesity, poor diet, and
inactivity,whicharelikelycontributingto
trends speciﬁcally in GDM and type 2 di-
abetes (15).
With respect to type 1 diabetes, no
clear trends have been previously estab-
lished among adults. Pregnant women
with pregestational diabetes have a much
greater risk of maternal and fetal compli-
cations, including preeclampsia and con-
genital abnormalities than nondiabetic
women (2). Not surprisingly, in our
study, hospitalizations coded with type 1
diabetes had the highest rates of cesarean
delivery, the longest lengths of stay, and
the highest total charges even after strati-
ﬁcation by mode of delivery. Rising rates
of type 1 diabetes, especially among the
youngestgroups,areaconcernbecauseof
the potential for increased future burden
of severe obstetric complications as these
women age and become pregnant again.
As with type 1 diabetes, outcomes of
type 2 diabetic pregnancies are also
marked by an increased risk for fetal mal-
formation and intrauterine death, as well
as other obstetric complications (2). Al-
though pregnancies with pregestational
diabetes have more adverse outcomes
than those with GDM, perhaps the great-
est signiﬁcance of GDM is the increased
risk of future development of type 2 dia-
betes that it confers (15). As GDM preva-
lence increases, the number of women
who enter subsequent pregnancies with
pregestational diabetes, as well as the
numberofwomenwhocarryanincreased
lifetime risk of developing type 2 diabe-
tes, is likely to increase.
Another factor that could have inﬂu-
enced diabetes trends in our study is
changes to screening recommendations
and diagnostic criteria that occurred dur-
ing the study time frame. In 1997, an ex-
pert committee of the American Diabetes
Association issued a report modifying the
diagnostic criteria for diabetes, which re-
sulted in the use of a fasting plasma glu-
cose test of 126 mg/dl, rather than 140
mg/dl as the preferred tool and cutoff to
diagnose type 2 diabetes (16). The antic-
ipated result of this modiﬁcation was that
an additional 2 million cases of diabetes
would be diagnosed, many of which
would be identiﬁed in younger individu-
als and as “early” type 2 diabetes (17).
Another modiﬁcation that occurred in
2000 was the American Diabetes Associ-
ation’s adoption of the Carpenter and
Coustan criteria for the diagnosis of GDM
via the 75-g or 100-g oral glucose toler-
ance test (18). Although use of the more
conservative1979NationalDiabetesData
Group criteria was still supported by the
American College of Obstetricians and
Gynecologists, adoption of the Carpenter
and Coustan criteria may have partially
contributed to the increased detection of
additional cases of GDM, particularly af-
ter 2000.
Table 2—Demographic and hospital characteristics of delivery hospitalizations by diabetes type in the U.S., 1994–2004
All diabetes GDM Type 1 diabetes Type 2 diabetes No diabetes
n 1,863,746 1,578,703 130,300 87,477 41,257,962
Age (years) (%)*
15–24 17.0 16.3 25.2 16.0 36.6
25–34 56.8 57.1 54.9 55.2 50.5
35 26.2 26.6 19.9 28.8 13.0
Hospital location (%)*
Rural 10.6 10.7 9.6 9.0 13.3
Urban 89.4 89.3 90.4 91.0 86.7
Primary expected payer (%)*
Medicaid/Medicare 34.1 33.1 37.9 43.3 36.7
Other (i.e., self-pay) 5.5 5.5 4.8 5.1 6.7
Private 60.5 61.4 57.3 51.6 56.6
Region of hospital (%)†
Northeast 17.9 18.5 15.2 12.3 17.5
Midwest 21.4 21.4 23.7 18.6 22.7
South 35.9 35.1 39.4 41.5 35.0
West 24.7 25.0 21.8 27.6 24.8
Mode of delivery (%)*
Vaginal 60.1 62.5 41.6 49.0 76.9
Cesarean 39.9 37.5 58.4 51.0 23.1
No. of procedures 2.3  0.01 2.3  0.01 2.3  0.02 2.3  0.03 2.1  0.01
No. of diagnoses* 5.2  0.02 5.0  0.02 6.6  0.03 6.7  0.04 3.6  0.01
Length of stay (days)* 3.1  0.02 3.0  0.01 4.4  0.05 3.7  0.04 2.4  0.01
Vaginal deliveries 2.4  0.01 2.3  0.01 3.3  0.05 2.8  0.04 2.0  0.01
Cesarean deliveries 4.3  0.03 4.1  0.03 5.2  0.07 4.5  0.05 3.7  0.01
Charges (U.S. $)*‡ 8,876  103 8,488  100 11,811  161 10,938  193 6,635  62
Vaginal deliveries 6,658  71 6,468  71 8,833  153 8,071  157 5,417  51




2 test and ANOVA). †Based on U.S. Census regions. ‡All charges adjusted for 2004 U.S. dollars.
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we also demonstrated urban location to
be signiﬁcantly associated with all diabe-
testypes.Thereisevidenceofurban/rural
disparities in diabetes prevalence, but
contrary to our results, rural areas appear
to carry a greater burden of the disease
(19).Reducedaccesstocareinruralareas
withthepotentialforunderdiagnosis,to-
gether with our inability to adjust for po-
tential drivers of urban/rural differences,
including race and socioeconomic fac-
tors, may in part explain the associations
we found with urban location.
We also demonstrated payer status,
speciﬁcally Medicaid/Medicare, to be a
signiﬁcant predictor of a diagnosis of dia-
betes. Previous studies of other health
outcomes using administrative data have
used payer status as a crude proxy for so-
cioeconomic status (SES) in the absence
of other more commonly used markers
(20,21). Since enrollment in Medicaid is
contingent on meeting low-income
thresholds and because low SES is a well-
documented risk factor for diabetes, this
may partly explain the association we
found between diabetes and Medicaid/
Medicarepayerstatus.Limitations,never-
theless, are present when using payer
status as an SES marker, and thus results
are interpreted with caution.
Finally, we also documented an asso-
ciation between southern region and a di-
abetes diagnosis at delivery for all types.
According to national diabetes estimates,
the U.S. South has the highest prevalence
estimates in the country (15). Similarly,
obesity, a major risk factor for both GDM
and type 2 diabetes, is also more pro-
nounced in the South (22). Regional dis-
parities may also be a reﬂection of
differences in screening, as well as differ-
ences in race, SES, and lifestyle factors,
which, analogous to differences in urban/
rural estimates, may account for the asso-
ciation found with region. Less clear,
however, is an explanation for the re-
gional differences that we also observed
with type 1 diabetes. Some hypotheses
havesuggestedthatexcessweightmayac-
celerate development of type 1 diabetes,
which could partly explain increasing
trends (23). Regional differences in obe-
sity may also be reﬂected in the associa-
tion with type 1 diabetes; however,
because this hypothesis has not been
thoroughly tested, explanations for the
regional differences in type 1 diabetes re-
main unclear.
There are some limitations with this
analysis. First, record identiﬁcation with
diabetes was based on discharge ICD-
9-CM codes without knowledge of the
criteria used to make the diagnosis. In
general, studies that use ICD-9-CM codes
todescribediseasetrendsmaysufferfrom
bias, depending on the validity of the
code for the condition being examined. A
previous study that evaluated ICD-9-CM
codes in hospital discharge data for use in
obstetric research reported high positive
predictive values (96%) and moderate
sensitivity (64%) for the full spectrum of
diabetes codes (24). Similar results were
reported in another study that assessed
the validity of hospital discharge data for
identifying diabetes-complicated births
(25). This result suggests the potential for
underestimation rather than overreport-
ing in our numbers but would not deter
from our conclusions regarding the im-
pact of diabetes among pregnant women
in the U.S. Similarly, because of the na-
ture of the data, we also cannot rule out
improvement in reporting quality over
time as a partial explanation for the tem-
poral increases. Population-based studies
of laboratory-based diagnoses of GDM
over similar time intervals, however, also
documented increasing trends similar to
what we report (5,6).
Second,becauseraceisnotconsistently
reported by all states in the NIS dataset, we
electedtoexcludeanyexaminationbyrace.
Totheextentthatsamplingandracereport-
ing varied throughout the study period, in-
terpretation of trends may be affected as it
wouldwithanyunmeasuredcovariate(e.g.,
obesity).Previousstudiesofdiabetestrends
in pregnancy with more reliable race data,
however, also demonstrated ﬁndings con-
sistent with our own, even after adjustment
for race (5,6). As a result, although we
cannot rule out the contribution of a pos-
Table 3—Adjusted odds of diabetes by select characteristics of delivery hospitalizations, 1994–2004
ORs (95% CI)
All diabetes GDM Type 1 diabetes Type 2 diabetes
Year
2004 1.52 (1.44–1.61) 1.51 (1.42–1.61) 1.28 (1.12–1.46) 4.09 (2.92–5.71)
1994 1.00 1.00 1.00 1.00
Age, categorized (years)
15–24 1.00 1.00 1.00 1.00
25–34 2.64 (2.61–2.68) 2.73 (2.69–2.76) 1.69 (1.63–1.75) 3.08 (2.93–3.25)
35 4.80 (4.72–4.89) 4.95 (4.86–5.04) 2.35 (2.24–2.46) 6.32 (5.95–6.72)
Hospital location
Rural 1.00 1.00 1.00 1.00
Urban 1.14 (1.11–1.17) 1.12 (1.09–1.16) 1.40 (1.31–1.50) 1.39 (1.26–1.54)
Primary expected payer
Medicaid/Medicare 1.29 (1.26–1.32) 1.24 (1.21–1.28) 1.30 (1.25–1.36) 1.94 (1.81–2.08)
Other (i.e., self pay) 0.94 (0.90–0.97) 0.95 (0.91–0.98) 0.79 (0.73–0.86) 1.08 (0.97–1.20)
Private 1.00 1.00 1.00 1.00
Region of hospital†
Northeast 0.99 (0.94–1.04) 1.00 (0.95–1.06) 0.98 (0.89–1.07) 0.64 (0.56–0.74)
Midwest 1.02 (0.98–1.06) 1.00 (0.96–1.04) 1.28 (1.18–1.39) 0.87 (0.76–0.99)
South 1.10 (1.06–1.14) 1.06 (1.01–1.10) 1.36 (1.26–1.46) 1.15 (1.02–1.30)
West 1.00 1.00 1.00 1.00
Data are ORs (95% CI). *Adjusted for all other characteristics in the table. †Based on U.S. Census regions.
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time to overall increases in diabetes in
pregnancy in the U.S., our results never-
theless remain consistent with those of
previousstudiesthatwereabletoaccount
for race.
We report increasing trends in all di-
abetes types among all age-groups from a
sample of delivery hospitalizations in the
U.S. from 1994 to 2004. Overall trends
were largely driven by those with a diag-
nosisforGDM,althoughthesharpestrate
increases were found among those with
type 2. Most concerning was the identiﬁ-
cation of a group of relatively young
women who have an increased lifetime
risk of future development of type 2 dia-
betes and obstetric complications with
subsequent pregnancies. Given the po-
tentialformaternalandperinatalmorbid-
ityandmortalityassociatedwithdiabetes,
it will be important to monitor trends
among the pregnant population to target
prevention strategies to minimize both
these risks and the anticipated burden on
the health care system.
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